| AMGEN INC. DL-,0001 |
| USA |
| Gesundheit |
| US0311621009 / 867900 |
| AMG (Frankfurt) / AMGN (NASDAQ) |
| FRA:AMG, ETR:AMG, AMG:GR, NASDAQ:AMGN |
| https://www.amgen.com/ |
|
Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on innovative medicines addressing serious illnesses in areas such as oncology, inflammation, cardiovascular disease, ..
>Volltext.. |
| 177327.73 Mio. EUR |
| 216446.65 Mio. EUR |
| 32348.9 Mio. EUR |
| 14515.46 Mio. EUR |
| 6764.29 Mio. EUR |
| 12.56 EUR |
| 49711.43 Mio. EUR |
| 10439.55 Mio. EUR |
| 9327.78 Mio. EUR |
| 0.48 |
| 2.95% |
| 23.1% |
| 8.4 EUR |
| 2.59% |
| 2.66% |
| 15.05.26 - 2.1666958€ 13.02.26 - 2.123604€ >weitere anzeigen... |
| - |
| AMGEN |
| 05.08.26 |